TOTAL | 2–17 | 18–34 | 35–49 | 50+ years | Male | Female | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | |
Mild | 111 | 3.7 (2.8–4.7) | 11 | 0.7 (0.4–1.4) | 37 | 4.4 (3.0–6.4) | 33 | 7.7 (5.5–10.6) | 30 | 12.8 (8.9–18.1 | 35 | 2.5 (1.7–3.6) | 76 | 4.7 (3.5–6.2) |
Moderate | 191 | 6.2 (5.3–7.3) | 30 | 1.9 (1.3–2.8) | 43 | 4.9 (3.5–6.7) | 62 | 14.7 (11.4–18.6) | 56 | 23.8 (18.8–29.7) | 90 | 6.2 (5.0–7.7) | 101 | 6.2 (4.9–7.9) |
Severe | 71 | 2.3 (1.8–3.0) | 19 | 1.3 (0.8–2.0) | 20 | 2.3 (1.4–3.6) | 15 | 3.6 (2.2–5.9) | 17 | 7.2 (4.4–11.8) | 38 | 2.6 (1.9–3.6) | 33 | 2.1 (1.4–2.9) |
All MSI | 373 | 12.2 (10.8–13.7) | 60 | 3.9 (3.0–5.1) | 100 | 11.5 (9.0–14.6) | 110 | 26.0 (21.8–30.6) | 103 | 43.8 (37.0–50.9) | 163 | 11.4 (9.7–13.3) | 210 | 13.0 (11–15.2) |